Search

Author/Creator Shields, Justin

1. Highly bioavailable silibinin nanoparticles inhibit HCV infection. Issue 10 (19th July 2016)

Authors:
Liu, Ching-Hsuan; Lin, Chun-Ching; Hsu, Wen-Chan; Chung, Chueh-Yao; Lin, Chih-Chan; Jassey, Alagie; Chang, Shun-Pang; Tai, Chen-Jei; Tai, Cheng-Jeng; Shields, Justin; Richardson, Christopher D; Yen, Ming-Hong; Tyrrell, D Lorne J; Lin, Liang-Tzung
Journal:
Gut
Issue:
Volume 66:Issue 10(2017)
Page Start:
1853
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. SARS-COV-2 recombinant Receptor-Binding-Domain (RBD) induces neutralizing antibodies against variant strains of SARS-CoV-2 and SARS-CoV-1. Issue 40 (24th September 2021)

Authors:
Law, John Lok Man; Logan, Michael; Joyce, Michael A.; Landi, Abdolamir; Hockman, Darren; Crawford, Kevin; Johnson, Janelle; LaChance, Gerald; Saffran, Holly A.; Shields, Justin; Hobart, Eve; Brassard, Raelynn; Arutyunova, Elena; Pabbaraju, Kanti; Croxen, Matthew; Tipples, Graham; Lemieux, M. Joan...
Journal:
Vaccine
Issue:
Volume 39:Issue 40(2021)
Page Start:
5769
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search